SS Innovations International (SSII) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 36.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.94% |
| Dec 31, 2025 | 196.59% |
| Sep 30, 2025 | 39.24% |
| Jun 30, 2025 | 91.24% |
| Mar 31, 2025 | -103.02% |
| Dec 31, 2024 | 0.21% |
| Sep 30, 2024 | -400.63% |
| Jun 30, 2024 | -58.44% |
| Mar 31, 2024 | 6.48% |
| Dec 31, 2023 | -1,541.80% |
| Sep 30, 2023 | -151.31% |
| Jun 30, 2023 | -146.06% |
| Mar 31, 2023 | -3,620.87% |
| Dec 31, 2022 | -191.31% |
| Sep 30, 2022 | -16.30% |
| Jun 30, 2022 | -82.39% |
| Mar 31, 2022 | 73.20% |
| Dec 31, 2021 | -59.10% |
| Sep 30, 2021 | -11.37% |
| Jun 30, 2021 | -87.16% |
| Mar 31, 2021 | 2.27% |
| Dec 31, 2020 | 78.95% |
| Sep 30, 2020 | 73.13% |
| Jun 30, 2020 | 59.13% |
| Mar 31, 2020 | 22.37% |
| Dec 31, 2019 | -380.99% |
| Sep 30, 2019 | -370.09% |
| Jun 30, 2019 | -162.28% |
| Mar 31, 2019 | -65.89% |
| Dec 31, 2018 | 53.77% |
| Sep 30, 2018 | -65.09% |
| Jun 30, 2018 | -9.68% |
| Mar 31, 2018 | -21.44% |
| Dec 31, 2017 | -143.26% |
| Sep 30, 2017 | 27.06% |
| Jun 30, 2017 | -333.32% |